Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 78,915 shares at $67.01 ($5.3M) on 2024-04-29, disclosed to the SEC on 2024-05-01.
Scheduled sale ($5.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.01 | 15,693 | $1.1M | 19.7% |
| 2 | $67.01 | 833 | $56K | 1.0% |
| 3 | $67.01 | 833 | $56K | 1.0% |
| 4 | $67.01 | 15,693 | $1.1M | 19.7% |
| 5 | $67.81 | 1,082 | $73K | 1.4% |
| 6 | $67.81 | 20,207 |
| $1.4M |
| 25.7% |
| 7 | $67.81 | 20,207 | $1.4M | 25.7% |
| 8 | $67.81 | 1,082 | $73K | 1.4% |
| 9 | $68.57 | 1,600 | $110K | 2.1% |
| 10 | $68.57 | 85 | $6K | 0.1% |
| 11 | $68.57 | 1,600 | $110K | 2.1% |
| Total | $67.51 avg | 78,915 | $5.3M | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |